Clinical Trial Update: Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization [NA]

View source ↗

Summary

A completed clinical trial from Inmunotek S.L. focusing on standardizing Phleum pratense and Dactylis glomerata allergen extracts for pollen-related allergies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Dermatitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Dactylis glomerata pollen extract (Dactylis glomerata pollen extract)
• Phleum pratense pollen extract (Phleum pratense pollen extract)

Snippet

Sponsor: Inmunotek S.L. | Conditions: Allergy Pollen, Allergic Reaction | NA | Status: COMPLETED